vs
Community West Bancshares（CWBC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Community West Bancshares的1.8倍（$69.8M vs $38.3M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 36.0%）
Community West Bancshares是一家总部位于美国加利福尼亚州的注册银行控股公司，依据银行控股公司相关法案全资持有Community West Bank，开展银行相关控股经营业务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CWBC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$38.3M
营收增速更快
RIGL
高出9.6%
11.6%
两年增速更快
RIGL
近两年复合增速
36.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.3M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 40.0% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 11.6% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.58 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CWBCRIGL
| Q4 25 | $38.3M | $69.8M | ||
| Q3 25 | $37.9M | $69.5M | ||
| Q2 25 | $35.7M | $101.7M | ||
| Q1 25 | $34.8M | $53.3M | ||
| Q4 24 | $34.3M | $57.6M | ||
| Q3 24 | $31.3M | $55.3M | ||
| Q2 24 | $30.5M | $36.8M | ||
| Q1 24 | $20.7M | $29.5M |
净利润CWBCRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $10.9M | $27.9M | ||
| Q2 25 | $7.8M | $59.6M | ||
| Q1 25 | $8.3M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $3.4M | $12.4M | ||
| Q2 24 | $-6.3M | $-1.0M | ||
| Q1 24 | $3.7M | $-8.2M |
毛利率CWBCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CWBCRIGL
| Q4 25 | 40.0% | 33.2% | ||
| Q3 25 | 39.8% | 40.9% | ||
| Q2 25 | 30.2% | 60.1% | ||
| Q1 25 | 32.7% | 23.9% | ||
| Q4 24 | 31.0% | 28.9% | ||
| Q3 24 | 13.3% | 25.4% | ||
| Q2 24 | -25.9% | 1.2% | ||
| Q1 24 | 23.2% | -23.6% |
净利率CWBCRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 28.7% | 40.2% | ||
| Q2 25 | 22.0% | 58.6% | ||
| Q1 25 | 23.8% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 10.8% | 22.5% | ||
| Q2 24 | -20.7% | -2.8% | ||
| Q1 24 | 17.8% | -27.9% |
每股收益（稀释后）CWBCRIGL
| Q4 25 | $0.58 | $14.11 | ||
| Q3 25 | $0.57 | $1.46 | ||
| Q2 25 | $0.41 | $3.28 | ||
| Q1 25 | $0.44 | $0.63 | ||
| Q4 24 | $0.29 | $0.82 | ||
| Q3 24 | $0.18 | $0.70 | ||
| Q2 24 | $-0.33 | $-0.06 | ||
| Q1 24 | $0.31 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $119.0M | $155.0M |
| 总债务越低越好 | $69.5M | $52.5M |
| 股东权益账面价值 | $409.6M | $391.5M |
| 总资产 | $3.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CWBCRIGL
| Q4 25 | $119.0M | $155.0M | ||
| Q3 25 | $121.6M | $137.1M | ||
| Q2 25 | $134.4M | $108.4M | ||
| Q1 25 | $148.4M | $77.1M | ||
| Q4 24 | $120.4M | $77.3M | ||
| Q3 24 | $149.0M | $61.1M | ||
| Q2 24 | $109.7M | $49.1M | ||
| Q1 24 | $61.0M | $49.5M |
总债务CWBCRIGL
| Q4 25 | $69.5M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $69.9M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CWBCRIGL
| Q4 25 | $409.6M | $391.5M | ||
| Q3 25 | $397.6M | $117.6M | ||
| Q2 25 | $380.0M | $81.9M | ||
| Q1 25 | $372.2M | $18.6M | ||
| Q4 24 | $362.7M | $3.3M | ||
| Q3 24 | $363.5M | $-14.6M | ||
| Q2 24 | $350.2M | $-29.9M | ||
| Q1 24 | $211.7M | $-31.7M |
总资产CWBCRIGL
| Q4 25 | $3.7B | $513.6M | ||
| Q3 25 | $3.6B | $242.5M | ||
| Q2 25 | $3.6B | $206.7M | ||
| Q1 25 | $3.6B | $176.0M | ||
| Q4 24 | $3.5B | $164.0M | ||
| Q3 24 | $3.5B | $139.4M | ||
| Q2 24 | $3.5B | $128.4M | ||
| Q1 24 | $2.4B | $126.5M |
负债/权益比CWBCRIGL
| Q4 25 | 0.17× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.19× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $43.6M | — |
| 自由现金流率自由现金流/营收 | 113.9% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $77.7M | — |
8季度趋势，按日历期对齐
经营现金流CWBCRIGL
| Q4 25 | $46.1M | $22.0M | ||
| Q3 25 | $13.2M | $24.0M | ||
| Q2 25 | $11.5M | $30.5M | ||
| Q1 25 | $11.1M | $-893.0K | ||
| Q4 24 | $22.2M | $14.5M | ||
| Q3 24 | $7.8M | $21.7M | ||
| Q2 24 | $5.2M | $302.0K | ||
| Q1 24 | $4.0M | $-5.0M |
自由现金流CWBCRIGL
| Q4 25 | $43.6M | — | ||
| Q3 25 | $12.8M | — | ||
| Q2 25 | $10.6M | — | ||
| Q1 25 | $10.8M | — | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | $3.6M | — |
自由现金流率CWBCRIGL
| Q4 25 | 113.9% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 30.9% | — | ||
| Q4 24 | 50.0% | — | ||
| Q3 24 | 16.7% | — | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 17.3% | — |
资本支出强度CWBCRIGL
| Q4 25 | 6.6% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.1% | — |
现金转化率CWBCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.21× | 0.86× | ||
| Q2 25 | 1.47× | 0.51× | ||
| Q1 25 | 1.33× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.29× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
